Drug-induced sexual dysfunction in rats

Current Protocols in Neuroscience

Volumn , Issue SUPPL.53, 2010, Pages

  Chan, Johnny S W ^a   Waldinger, Marcel D ^a,b   Olivier, Berend ^a,c   Oosting, Ronald S ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b LEYENBURG HOSPITAL   (Netherlands)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

dysfunction; ejaculation; rats; sexual behavior; SSRI

Indexed keywords

ESTRADIOL; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL HOUSING; ANIMAL MODEL; BODY POSTURE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DATA ANALYSIS; DRUG DOSE COMPARISON; DRUG INDUCED DISEASE; EJACULATION; EXPERIMENTAL DESIGN; FEMALE; HABITUATION; INTROMISSION; LIGHT DARK CYCLE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; WISTAR RAT;

ANIMALS; BEHAVIOR, ANIMAL; COPULATION; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FEMALE; GENITALIA, MALE; MALE; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SEXUAL BEHAVIOR, ANIMAL; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 78449297744     PISSN: 19348584     EISSN: 19348576     Source Type: Journal    
DOI: 10.1002/0471142301.ns0934s53     Document Type: Review

References (22)

1. gmo, A., and, Ellingsen, E., 2003. Relevance of non-human animal studies to the understanding of human sexuality. Scand. J. Psychol. 44: 293-301.
2. Ahlenius, S., K. Larsson, K., and, Svensson, L., 1980. Further evidence for an inhibitory role of central 5-HT in male rat sexual behavior. Psychopharmacology 68: 217-220.
3. Aversa, A., Bruzziches, R., Pili, M., and, Spera, G., 2006. Phosphodiesterase 5 inhibitors in the treatment of erectile dysfunction. Curr. Pharm. Des. 12: 3467-3484. (Pubitemid 44400484)
4. Balon, R., 2006. SSRI-associated sexual dysfunction. Am. J. Psychiatry 163: 1504-1509.
5. Chan, J.S., Olivier, B., de Jong, T.R., Snoeren, E.M., Kooijman, E., van Hasselt, F.N., Limpens, J.H., Kas, M.J., Waldinger, M.D., and, Oosting, R.S., 2008, Translational research into sexual disorders: Pharmacology and genomics. Eur. J. Pharmacol. 585: 426-435.
6. de Jong, T.R., Pattij, T., Veening, J.G., Dederen, P.J., Waldinger, M.D., Cools, A.R., and, Olivier, B., 2005a. Effects of chronic paroxetine pretreatment on (/-)-8-hydroxy-2-(di-n-propyl-amino)tetralin induced c-fos expression following sexual behavior. Neuroscience 134: 1351-1361.
7. de Jong, T.R., Pattij, T., Veening, J.G., Waldinger, M.D., Cools, A.R., and, Olivier, B., 2005b. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: Comparison of fluvoxamine and paroxetine. Psychopharmacology 179: 509-515.
8. Lorrain, D.S., Matuszewich, L., Friedman, R.D., and, Hull, E.M., 1997. Extracellular serotonin in the lateral hypothalamic area is increased during the postejaculatory interval and impairs copulation in male rats. J. Neurosci. 17: 9361-9366.
9. Marson, L., and, McKenna, K.E., 1992. A role for 5-hydroxytryptamine in descending inhibition of spinal sexual reflexes. Exp. Brain Res. 88: 313-320.
10. Montgomery, S.A., Baldwin, D.S., and, Riley, A., 2002. Antidepressant medications: A review of the evidence for drug-induced sexual dysfunction. J. Affect. Disord. 69: 119-140.
11. Mos, J., Mollet, I., Tolboom, J.T., Waldinger, M.D., and, Olivier, B., 1999. A comparison of the effects of different serotonin reuptake blockers on sexual behaviour of the male rat. Eur. Neuropsychopharmacol. 9: 123-135.
12. Olivier, B., Chan, J.S., Pattij, T., de Jong, T.R., Oosting, R.S., Veening, J.G., and, Waldinger, M.D., 2006. Psychopharmacology of male rat sexual behavior: modeling human sexual dysfunctions ? Int. J. Impot. Res. 18: S14-S23.
13. Pattij, T., de Jong, T.R., Uitterdijk, A., Waldinger, M.D., Veening, J.G., Cools, A.R., van der Graaf, P.H., and, Olivier, B., 2005. Individual differences in male rat ejaculatory behaviour: Searching for models to study ejaculation disorders. Eur. J. Neurosci. 22: 724-734.
14. Portfors, C.V., 2007. Types and functions of ultrasonic vocalizations in laboratory rats and mice. J. Am. Assoc. Lab. Anim. Sci. 46: 28-34.
15. Rosen, R.C., Lane, R.M., and, Menza, M., 1999. Effects of SSRIs on sexual function: a critical review. J. Clin. Psychopharmacol. 19: 67-85.
16. Rosenzweig-Lipson, S., Beyer, C.E., Hughes, Z.A., Khawaja, X., Rajarao, S.J., Malberg, J.E., Rahman, Z., Ring, R.H., and, Schechter, L.E., 2007. Differentiating antidepressants of the future: Efficacy and safety. Pharmacol. Ther. 113: 134-153.
17. Timmermans, P.J.A., 1978. Social Behavior in the Rat. Ph.D Thesis, University of Nijmegen.
18. Vega Matuszcyk, J., Larsson, K., and, Eriksson, E., 1998. The selective serotonin reuptake inhibitor fluoxetine reduces sexual motivation in male rats. Pharmacol. Biochem. Behav. 60: 527-532.
19. Waldinger, M.D., Hengeveld, M.W., Zwinderman, A.H., and, Olivier, B., 1998. Effect of SSRI antidepressants on ejaculation: A double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J. Clin. Psychopharmacol. 18: 274-281.
20. Waldinger, M.D., Zwinderman, A.H., and, Olivier, B., 2001a. Antidepressants and ejaculation: A double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone. J. Clin. Psychopharmacol. 21: 293-297.
21. Waldinger, M.D., Zwinderman, A.H., and, Olivier, B., 2001b. SSRIs and ejaculation: A double-blind, randomized, fixed-dose study with paroxetine and citalopram. J. Clin. Psychopharmacol. 21: 556-560.
22. Waldinger, M.D., van De Plas, A., Pattij, T., van Oorschot, R., Coolen, L.M., Veening, J.G., and, Olivier, B., 2002. The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment. Psychopharmacology 160: 283-289.